![](/img/cover-not-exists.png)
Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer : A phase 1 trial
Allyson J. Ocean, Kenneth L. Pennington, Michael J. Guarino, Arif Sheikh, Tanios Bekaii-Saab, Aldo N. Serafini, Daniel Lee, Max W. Sung, Seza A. Gulec, Stanley J. Goldsmith, Timothy Manzone, Michael HVolume:
aop
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/cncr.27592
File:
PDF, 995 KB
english, 2012